Company / Revenue per Share
BIOCRYST PHARMACEUTICALS INC Revenue per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.34
FY2017
5-year range
-
FY2016-FY2017
Trend
-5.0%
vs FY2016
Sector context
#122 of 154
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's revenue per share of $0.34 is lower than 79% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
0.34 in FY2017.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 154This company $0.34 Sector average $10.35
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2017, revenue per share decreased 5.0% year-over-year.
- Ranks #122 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.34 | -5.0% |
| FY2016 | $0.36 | -46.4% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026